FDA.reportPublic FDA data

CALCIPOTRIENE

Substance profile for UNII 143NQ3779B, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for CALCIPOTRIENE
Structure render from PubChem CID 5288783

Substance Identity#

UNII
143NQ3779B
Preferred term
CALCIPOTRIENE
Registry number
112965-21-6
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C27H40O3
Chemical structure for CALCIPOTRIENE
Structure render from PubChem CID 5288783

Chemical And Database Identifiers#

InChIKey
LWQQLNNNIPYSNX-UROSTWAQSA-N
SMILES
C[C@H](\C=C\[C@@H](O)C1CC1)[C@H]2CC[C@@H]3[C@]2(C)CCC\C3=C/C=C4/C[C@@H](O)C[C@H](O)C4=C
RxCUI
29365
PubChem
5288783
NCIt
C28900
INN ID
6376

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound5288783https://pubchem.ncbi.nlm.nih.gov/compound/5288783
PubChem InChIKey SearchLWQQLNNNIPYSNX-UROSTWAQSA-Nhttps://pubchem.ncbi.nlm.nih.gov/#query=LWQQLNNNIPYSNX-UROSTWAQSA-N
RxNorm29365https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=29365
NCI ThesaurusC28900https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C28900
FDA Substance Registration System143NQ3779Bhttps://precision.fda.gov/uniisearch/srs/unii/143NQ3779B

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
CALCIPOTRIENEACTIVE MOIETY143NQ3779BThese highlights do not include all the information needed to use Taclonex ® Ointment safely and effectively. See Full Prescribing Information for Taclonex ® Ointment. Taclonex ® (calcipotriene 0.005% and betamethasone dipropionate 0.064%) Ointment For topical use only Initial U.S. Approval: 2006.4
CALCIPOTRIENEACTIVE MOIETY143NQ3779BThese highlights do not include all the information needed to use Taclonex Scalp® Topical Suspension safely and effectively. See full prescribing information for Taclonex Scalp® Topical Suspension. Initial U.S. Approval: 20061
CALCIPOTRIENEACTIVE INGREDIENT143NQ3779BThese highlights do not include all the information needed to use Taclonex Scalp® Topical Suspension safely and effectively. See full prescribing information for Taclonex Scalp® Topical Suspension. Initial U.S. Approval: 20061
CALCIPOTRIENEACTIVE INGREDIENT143NQ3779BDovonex ® (calcipotriene cream) Cream, 0.005%1
CALCIPOTRIENEACTIVE MOIETY143NQ3779BDovonex ® (calcipotriene cream) Cream, 0.005%1
CALCIPOTRIENEACTIVE INGREDIENT143NQ3779B1c02cc96-ecaa-467b-9acb-7cae57ec8e874
calcipotrieneACTIVE MOIETY143NQ3779B1c02cc96-ecaa-467b-9acb-7cae57ec8e874
CALCIPOTRIENEACTIVE MOIETY143NQ3779BTACLONEX (CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE) SUSPENSION [LEO PHARMA INC.]15
CALCIPOTRIENEACTIVE INGREDIENT143NQ3779BSORILUX (CALCIPOTRIENE) AEROSOL, FOAM [STIEFEL LABORATORIES INC]11
CALCIPOTRIENEACTIVE MOIETY143NQ3779BSORILUX (CALCIPOTRIENE) AEROSOL, FOAM [STIEFEL LABORATORIES INC]11
CALCIPOTRIENEACTIVE MOIETY143NQ3779BTACLONEX (CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE) OINTMENT [LEO PHARMA INC.]7
CALCIPOTRIENEACTIVE INGREDIENT143NQ3779BDOVONEX (CALCIPOTRIENE) CREAM [LEO PHARMA INC.]6
CALCIPOTRIENEACTIVE MOIETY143NQ3779BDOVONEX (CALCIPOTRIENE) CREAM [LEO PHARMA INC.]6
CALCIPOTRIENEACTIVE MOIETY143NQ3779BCALCIPOTRIENE 0.005% AND BETAMETHASONE DIPROPIONATE 0.064% OINTMENT [SANDOZ INC.]4
CALCIPOTRIENEACTIVE INGREDIENT143NQ3779BCALCIPOTRIENE 0.005% AND BETAMETHASONE DIPROPIONATE 0.064% OINTMENT [SANDOZ INC.]4
CALCIPOTRIENEACTIVE MOIETY143NQ3779BCALCIPOTRIENE SOLUTION [HI-TECH PHARMACAL CO., INC.]4
CALCIPOTRIENEACTIVE INGREDIENT143NQ3779BDOVONEX (CALCIPOTRIENE) SOLUTION [LEO PHARMA INC.]4
CALCIPOTRIENEACTIVE MOIETY143NQ3779BDOVONEX (CALCIPOTRIENE) SOLUTION [LEO PHARMA INC.]4
CALCIPOTRIENEACTIVE INGREDIENT143NQ3779BDOVONEX (CALCIPOTRIENE) SOLUTION [WARNER CHILCOTT (US), LLC]4
CALCIPOTRIENEACTIVE MOIETY143NQ3779BDOVONEX (CALCIPOTRIENE) SOLUTION [WARNER CHILCOTT (US), LLC]4
CalcipotrieneACTIVE INGREDIENT143NQ3779BCALCIPOTRIENE (CALCIPOTRIENE) SOLUTION [G&W LABORATORIES, INC.]3
CalcipotrieneACTIVE MOIETY143NQ3779BCALCIPOTRIENE (CALCIPOTRIENE) SOLUTION [G&W LABORATORIES, INC.]3
CALCIPOTRIENEACTIVE MOIETY143NQ3779BCALCIPOTRIENE OINTMENT [GLENMARK PHARMACEUTICALS INC., USA]3
CALCIPOTRIENEACTIVE INGREDIENT143NQ3779BCALCIPOTRIENE OINTMENT [GLENMARK PHARMACEUTICALS INC., USA]3
calcipotrieneACTIVE MOIETY143NQ3779BCALCIPOTRIENE SOLUTION [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]3
calcipotrieneACTIVE INGREDIENT143NQ3779BCALCIPOTRIENE SOLUTION [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]3
CALCIPOTRIENEACTIVE INGREDIENT143NQ3779BDOVONEX (CALCIPOTRIENE) CREAM [WARNER CHILCOTT (US), LLC]3
CALCIPOTRIENEACTIVE MOIETY143NQ3779BDOVONEX (CALCIPOTRIENE) CREAM [WARNER CHILCOTT (US), LLC]3
CALCIPOTRIENEACTIVE INGREDIENT143NQ3779BTACLONEX (CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE) OINTMENT [WARNER CHILCOTT (US), LLC]3
CALCIPOTRIENEACTIVE MOIETY143NQ3779BTACLONEX (CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE) OINTMENT [WARNER CHILCOTT (US), LLC]3
CALCIPOTRIENEACTIVE MOIETY143NQ3779BCALCIPOTRIENE CREAM [PRASCO LABORATORIES]2
CALCIPOTRIENEACTIVE INGREDIENT143NQ3779BCALCIPOTRIENE CREAM [PRASCO LABORATORIES]2
CALCIPOTRIENEACTIVE INGREDIENT143NQ3779BCALCIPOTRIENE OINTMENT [PRASCO LABORATORIES]2
CALCIPOTRIENEACTIVE MOIETY143NQ3779BCALCIPOTRIENE OINTMENT [PRASCO LABORATORIES]2
CalcipotrieneACTIVE MOIETY143NQ3779BCALCIPOTRIENE OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.]2
CalcipotrieneACTIVE INGREDIENT143NQ3779BCALCIPOTRIENE OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.]2
CALCIPOTRIENEACTIVE MOIETY143NQ3779BCALCIPOTRIENE SOLUTION [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC.]2
CALCIPOTRIENEACTIVE INGREDIENT143NQ3779BCALCIPOTRIENE SOLUTION [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC.]2
CalcipotrieneACTIVE MOIETY143NQ3779BCALCITRENE (CALCIPOTRIENE) OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.]2
CalcipotrieneACTIVE INGREDIENT143NQ3779BCALCITRENE (CALCIPOTRIENE) OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.]2
CALCIPOTRIENEACTIVE MOIETY143NQ3779BENSTILAR (CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE) AEROSOL, FOAM [LEO PHARMA INC.]2
CALCIPOTRIENEACTIVE MOIETY143NQ3779BTACLONEX SCALP (CALCIPOTRIENE 0.005% AND BETAMETHASONE DIPROPIONATE 0.064%) SPRAY, METERED [WARNER CHILCOTT (US), LLC]2
CALCIPOTRIENEACTIVE INGREDIENT143NQ3779BTACLONEX SCALP (CALCIPOTRIENE 0.005% AND BETAMETHASONE DIPROPIONATE 0.064%) SPRAY, METERED [WARNER CHILCOTT (US), LLC]2
CALCIPOTRIENEACTIVE INGREDIENT143NQ3779BCALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE OINTMENT [PERRIGO NEW YORK INC]1
CALCIPOTRIENEACTIVE MOIETY143NQ3779BCALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE OINTMENT [PERRIGO NEW YORK INC]1
CALCIPOTRIENEACTIVE INGREDIENT143NQ3779BCALCIPOTRIENE CREAM [GLENMARK PHARMACEUTICALS INC.,USA]1
CALCIPOTRIENEACTIVE MOIETY143NQ3779BCALCIPOTRIENE CREAM [GLENMARK PHARMACEUTICALS INC.,USA]1
CALCIPOTRIENEACTIVE MOIETY143NQ3779BCALCIPOTRIENE CREAM [SANDOZ INC.]1
CALCIPOTRIENEACTIVE INGREDIENT143NQ3779BCALCIPOTRIENE CREAM [SANDOZ INC.]1